Constellium, IBD Stock Of The Day, Forges Bullish Entry After 72% Rally Amid Accelerating Growth
Corroborated by 1 source from 1 publisher
globalbusiness4d ago
TL;DR
According to investors.com, constellium Constellium CSTM $ 25.10 $0.23 0.89% 43% IBD Stock Analysis Working on three-weeks-tight entry of 27.41, early buy point of 25.85 Relative strength line at 52-week highs Earnings, sales growth accelerating IBD Composite Rating 94/99 Industry Group Ranking 113/197 Emerging Pattern Three Weeks Tight Three Weeks Tight After a breakout a stock will sometimes consolidate tightly.